• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德国一家三级保健中心在 SARS-CoV-2 大流行第一波期间住院 COVID-19 患者的临床和病毒学特征:一项前瞻性观察研究。

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.

机构信息

Department of Infectious Diseases and Respiratory Medicine Berlin, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.

Institute of Virology, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany.

出版信息

Infection. 2021 Aug;49(4):703-714. doi: 10.1007/s15010-021-01594-w. Epub 2021 Apr 22.

DOI:10.1007/s15010-021-01594-w
PMID:33890243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8061715/
Abstract

PURPOSE

Adequate patient allocation is pivotal for optimal resource management in strained healthcare systems, and requires detailed knowledge of clinical and virological disease trajectories. The purpose of this work was to identify risk factors associated with need for invasive mechanical ventilation (IMV), to analyse viral kinetics in patients with and without IMV and to provide a comprehensive description of clinical course.

METHODS

A cohort of 168 hospitalised adult COVID-19 patients enrolled in a prospective observational study at a large European tertiary care centre was analysed.

RESULTS

Forty-four per cent (71/161) of patients required invasive mechanical ventilation (IMV). Shorter duration of symptoms before admission (aOR 1.22 per day less, 95% CI 1.10-1.37, p < 0.01) and history of hypertension (aOR 5.55, 95% CI 2.00-16.82, p < 0.01) were associated with need for IMV. Patients on IMV had higher maximal concentrations, slower decline rates, and longer shedding of SARS-CoV-2 than non-IMV patients (33 days, IQR 26-46.75, vs 18 days, IQR 16-46.75, respectively, p < 0.01). Median duration of hospitalisation was 9 days (IQR 6-15.5) for non-IMV and 49.5 days (IQR 36.8-82.5) for IMV patients.

CONCLUSIONS

Our results indicate a short duration of symptoms before admission as a risk factor for severe disease that merits further investigation and different viral load kinetics in severely affected patients. Median duration of hospitalisation of IMV patients was longer than described for acute respiratory distress syndrome unrelated to COVID-19.

摘要

目的

在资源紧张的医疗体系中,充分的患者分配对于优化资源管理至关重要,这需要详细了解临床和病毒学疾病轨迹。本研究的目的是确定与需要有创机械通气(IMV)相关的风险因素,分析有创和无创机械通气患者的病毒动力学,并对临床病程进行全面描述。

方法

分析了在一家大型欧洲三级保健中心进行的一项前瞻性观察性研究中纳入的 168 例住院成年 COVID-19 患者的队列。

结果

44%(71/161)的患者需要有创机械通气(IMV)。入院前症状持续时间较短(每减少 1 天的比值比 1.22,95%CI 1.10-1.37,p<0.01)和高血压病史(比值比 5.55,95%CI 2.00-16.82,p<0.01)与需要 IMV 相关。接受 IMV 的患者的 SARS-CoV-2 最大浓度更高、下降速度更慢、排毒时间更长(33 天,IQR 26-46.75,与非 IMV 患者的 18 天,IQR 16-46.75 相比,p<0.01)。非 IMV 患者的住院中位时间为 9 天(IQR 6-15.5),而 IMV 患者为 49.5 天(IQR 36.8-82.5)。

结论

我们的研究结果表明,入院前症状持续时间较短是疾病严重程度的一个危险因素,值得进一步研究。严重感染患者的病毒载量动力学也不同。接受 IMV 的患者的中位住院时间比与 COVID-19 无关的急性呼吸窘迫综合征的描述时间更长。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7884/8316160/e0275ee35d33/15010_2021_1594_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7884/8316160/8c7bd964da8b/15010_2021_1594_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7884/8316160/bda0fadf5639/15010_2021_1594_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7884/8316160/e0275ee35d33/15010_2021_1594_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7884/8316160/8c7bd964da8b/15010_2021_1594_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7884/8316160/bda0fadf5639/15010_2021_1594_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7884/8316160/e0275ee35d33/15010_2021_1594_Fig3_HTML.jpg

相似文献

1
Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study.德国一家三级保健中心在 SARS-CoV-2 大流行第一波期间住院 COVID-19 患者的临床和病毒学特征:一项前瞻性观察研究。
Infection. 2021 Aug;49(4):703-714. doi: 10.1007/s15010-021-01594-w. Epub 2021 Apr 22.
2
Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19).2019冠状病毒病(COVID-19)患者病毒RNA长期脱落的相关因素
Clin Infect Dis. 2020 Jul 28;71(15):799-806. doi: 10.1093/cid/ciaa351.
3
Severe infection due to the SARS-CoV-2 coronavirus: Experience of a tertiary hospital with COVID-19 patients during the 2020 pandemic.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染:一家三级医院在2020年大流行期间治疗新型冠状病毒肺炎(COVID-19)患者的经验。
Med Intensiva (Engl Ed). 2020 Dec;44(9):525-533. doi: 10.1016/j.medin.2020.05.018. Epub 2020 Jun 19.
4
The role of CPAP as a potential bridge to invasive ventilation and as a ceiling-of-care for patients hospitalized with Covid-19-An observational study.CPAP 作为一种潜在的有创通气桥接手段和 COVID-19 住院患者的治疗上限的作用:一项观察性研究。
PLoS One. 2020 Dec 31;15(12):e0244857. doi: 10.1371/journal.pone.0244857. eCollection 2020.
5
Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study.国际严重急性呼吸系统和新发感染联盟(ISARIC)COVID-19 研究中严重 COVID-19 患者的呼吸支持:一项前瞻性、多国、观察性研究。
Crit Care. 2022 Sep 13;26(1):276. doi: 10.1186/s13054-022-04155-1.
6
Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study.地塞米松对住院 COVID-19 患者 SARS-CoV-2 浓度动力学和抗体反应的影响:一项前瞻性观察研究的结果。
Clin Microbiol Infect. 2021 Oct;27(10):1520.e7-1520.e10. doi: 10.1016/j.cmi.2021.06.008. Epub 2021 Jun 15.
7
Risk factors for ventilator-associated lower respiratory tract infection in COVID-19, a retrospective multicenter cohort study in Sweden.COVID-19 呼吸机相关性下呼吸道感染的危险因素:瑞典回顾性多中心队列研究。
Acta Anaesthesiol Scand. 2024 Feb;68(2):226-235. doi: 10.1111/aas.14338. Epub 2023 Sep 26.
8
Clinical characteristics, symptoms and outcomes of 1054 adults presenting to hospital with suspected COVID-19: A comparison of patients with and without SARS-CoV-2 infection.1054 名因疑似 COVID-19 住院的成年人的临床特征、症状和转归:伴有和不伴有 SARS-CoV-2 感染患者的比较。
J Infect. 2020 Dec;81(6):937-943. doi: 10.1016/j.jinf.2020.09.033. Epub 2020 Sep 28.
9
A comprehensive physical functional assessment of survivors of critical care unit stay due to COVID-19.因 COVID-19 而入住重症监护病房的幸存者的全面身体功能评估。
Crit Care Sci. 2024 May 3;36:e20240284en. doi: 10.62675/2965-2774.20240284-en. eCollection 2024.
10
Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study.10021 例新冠肺炎住院患者的病例特征、资源利用和结局:一项观察性研究。
Lancet Respir Med. 2020 Sep;8(9):853-862. doi: 10.1016/S2213-2600(20)30316-7. Epub 2020 Jul 28.

引用本文的文献

1
Soluble ACE2 correlates with severe COVID-19 and can impair antibody responses.可溶性血管紧张素转换酶2(sACE2)与重症新型冠状病毒肺炎(COVID-19)相关,且会损害抗体反应。
iScience. 2024 Feb 24;27(3):109330. doi: 10.1016/j.isci.2024.109330. eCollection 2024 Mar 15.
2
[Not Available].[无可用内容]
Tunis Med. 2023 Apr 5;101(4):426-432.
3
Plasma proteomics of SARS-CoV-2 infection and severity reveals impact on Alzheimer's and coronary disease pathways.新型冠状病毒感染与严重程度的血浆蛋白质组学揭示了对阿尔茨海默病和冠心病通路的影响。

本文引用的文献

1
Acute respiratory distress syndrome: the Berlin Definition.急性呼吸窘迫综合征:柏林定义。
JAMA. 2012 Jun 20;307(23):2526-33. doi: 10.1001/jama.2012.5669.
iScience. 2023 Apr 21;26(4):106408. doi: 10.1016/j.isci.2023.106408. Epub 2023 Mar 14.
4
Short- and long-term T cell and antibody responses following dexamethasone treatment in COVID-19.地塞米松治疗 COVID-19 后短期和长期的 T 细胞和抗体反应。
JCI Insight. 2023 Apr 24;8(8):e166711. doi: 10.1172/jci.insight.166711.
5
A proteomic survival predictor for COVID-19 patients in intensive care.一种用于重症监护病房中新冠患者的蛋白质组学生存预测指标。
PLOS Digit Health. 2022 Jan 18;1(1):e0000007. doi: 10.1371/journal.pdig.0000007. eCollection 2022 Jan.
6
Cenicriviroc for the treatment of COVID-19: first interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial.西尼利尤单抗治疗 COVID-19:一项随机、安慰剂对照、研究者发起、双盲 II 期试验的首次中期结果。
J Glob Antimicrob Resist. 2023 Mar;32:44-47. doi: 10.1016/j.jgar.2022.12.004. Epub 2022 Dec 23.
7
Systemic corticosteroids for the treatment of COVID-19: Equity-related analyses and update on evidence.全身性皮质类固醇治疗 COVID-19:与公平相关的分析和证据更新。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD014963. doi: 10.1002/14651858.CD014963.pub2.
8
SARS-CoV-2 variant Alpha has a spike-dependent replication advantage over the ancestral B.1 strain in human cells with low ACE2 expression.SARS-CoV-2 变异株 Alpha 在 ACE2 表达水平较低的人类细胞中相对于原始 B.1 株具有依赖 Spike 的复制优势。
PLoS Biol. 2022 Nov 16;20(11):e3001871. doi: 10.1371/journal.pbio.3001871. eCollection 2022 Nov.
9
Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021.估计 2020 年和 2021 年有症状 COVID-19 后持续性疲劳、认知和呼吸症状群个体在全球的比例。
JAMA. 2022 Oct 25;328(16):1604-1615. doi: 10.1001/jama.2022.18931.
10
The human host response to monkeypox infection: a proteomic case series study.人类对猴痘感染的宿主反应:一项蛋白质组学病例系列研究。
EMBO Mol Med. 2022 Nov 8;14(11):e16643. doi: 10.15252/emmm.202216643. Epub 2022 Sep 28.